| Evaluating social media networks in medicines safety surveillance: two case studies PM Coloma, B Becker, MCJM Sturkenboom, EM Van Mulligen, JA Kors Drug safety 38, 921-930, 2015 | 62 | 2015 |
| Evaluation of a multinational, multilingual vaccine debate on Twitter BFH Becker, HJ Larson, J Bonhoeffer, EM Van Mulligen, JA Kors, ... Vaccine 34 (50), 6166-6171, 2016 | 49 | 2016 |
| Extraction of chemical-induced diseases using prior knowledge and textual information E Pons, BFH Becker, SA Akhondi, Z Afzal, EM Van Mulligen, JA Kors Database 2016, baw046, 2016 | 39 | 2016 |
| CodeMapper: semiautomatic coding of case definitions. A contribution from the ADVANCE project BFH Becker, P Avillach, S Romio, EM van Mulligen, D Weibel, ... Pharmacoepidemiology and drug safety 26 (8), 998-1005, 2017 | 33 | 2017 |
| Chemical entity recognition in patents by combining dictionary-based and statistical approaches SA Akhondi, E Pons, Z Afzal, H van Haagen, BFH Becker, KM Hettne, ... Database 2016, baw061, 2016 | 24 | 2016 |
| Effect of nusinersen on motor, respiratory and bulbar function in early-onset spinal muscular atrophy A Pechmann, M Behrens, K Dörnbrack, A Tassoni, S Stein, S Vogt, ... Brain 146 (2), 668-677, 2023 | 22 | 2023 |
| RELigator: chemical-disease relation extraction using prior knowledge and textual information E Pons, B Becker, SA Akhondi, Z Afzal, E van Mulligen, J Kors Proceedings of the Fifth BioCreative Challenge Evaluation Workshop 1, 247, 2015 | 19 | 2015 |
| Quantifying outcome misclassification in multi-database studies: the case study of pertussis in the ADVANCE project R Gini, CN Dodd, K Bollaerts, C Bartolini, G Roberto, C Huerta-Alvarez, ... Vaccine 38, B56-B64, 2020 | 16 | 2020 |
| Explaining counterexamples with giant-step assertion checking B Becker, CB Lourenço, C Marché arXiv preprint arXiv:2108.02967, 2021 | 14 | 2021 |
| Cathepsin D as biomarker in cerebrospinal fluid of nusinersen‐treated patients with spinal muscular atrophy DC Schorling, H Kölbel, A Hentschel, A Pechmann, N Meyer, B Wirth, ... European journal of neurology 29 (7), 2084-2096, 2022 | 13 | 2022 |
| Improvements in walking distance during nusinersen treatment–a prospective 3-year SMArtCARE registry study A Pechmann, M Behrens, K Dörnbrack, A Tassoni, F Wenzel, S Stein, ... Journal of Neuromuscular Diseases 10 (1), 29-40, 2023 | 10 | 2023 |
| Analysing installation scenarios of Debian packages B Becker, N Jeannerod, C Marché, Y Régis-Gianas, M Sighireanu, ... International Conference on Tools and Algorithms for the Construction and …, 2020 | 7 | 2020 |
| Ghost code in action: Automated verification of a symbolic interpreter B Becker, C Marché Verified Software. Theories, Tools, and Experiments: 11th International …, 2020 | 7 | 2020 |
| Rapport d'avancement sur la vérification formelle des algorithmes de ParcourSup B Becker, JC Filliâtre, C Marché Université Paris-Saclay, 2020 | 6 | 2020 |
| Masking by vaccines in pediatric drug safety signal detection in the EudraVigilance database C Dodd, A Pacurariu, OU Osokogu, D Weibel, C Ferrajolo, DH Vo, ... Pharmacoepidemiology and drug safety 27 (11), 1249-1256, 2018 | 6 | 2018 |
| Revision 2 of CoLiS language: formal syntax, semantics, concrete and symbolic interpreters B Becker, N Jeannerod, C Marché, R Treinen ANR, 2019 | 3 | 2019 |
| Preferences in Cardinal Direction M Ragni, B Becker Proceedings of the 32nd Annual Conference of the Cognitive Science Society …, 2010 | 3 | 2010 |
| The CoLiS platform for the analysis of maintainer scripts in Debian software packages B Becker, N Jeannerod, C Marché, Y Régis-Gianas, M Sighireanu, ... International Journal on Software Tools for Technology Transfer 24 (5), 717-733, 2022 | 2 | 2022 |
| Vaccine semantics: Automatic methods for recognizing, representing, and reasoning about vaccine-related information B Becker | 2 | 2019 |
| What Can Social Media Networks Contribute To Medicines Safety Surveillance? PM Coloma, B Becker, MCJM Sturkenboom, EM van Mulligen, JA Kors PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 24, 467-468, 2015 | 2 | 2015 |
